top of page

    Reconstruction and Computational Modelling for Inherited Metabolic Diseases

    Accelerating the diagnosis and personalising the management

    of inherited metabolic diseases.


    Key features of Recon4IMD

    • Overall objectives: Accelerate diagnosis and personalise management of inherited metabolic diseases.

    • Primary output: Clinically validated decision support tools enabling accelerated diagnosis and personalised management of inherited metabolic diseases, based on genomic, proteomic, and metabolomic data-driven computational models.

    • Sustainability: Development of academic technology to meet medical regulatory standards and a roadmap for exploitation within a European foundation to aid personalised diagnosis and management of inherited metabolic diseases.

    • Implemented by: A group of world-class scientists and clinicians from a diversity of disciplines who have collaborated multiple times and have a track record of leading key national and EU-funded initiatives to deliver high-impact results.

    News & Events

    20240611_192027 (1).heic

    Recon4IMD F2F 2024,
    Galway, Ireland

    Latest Publications


    Integration of proteomics with genomics and transcriptomics increases the diagnostic rate of Mendelian disorders

    Here, we demonstrate the effectiveness of combining genomics, transcriptomics, and, for the first time, proteomics and phenotypic descriptors, in a systematic diagnostic approach to discover the genetic cause of mitochondrial diseases.

    bottom of page